<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00598377</url>
  </required_header>
  <id_info>
    <org_study_id>2007/233</org_study_id>
    <secondary_id>2007/233</secondary_id>
    <nct_id>NCT00598377</nct_id>
  </id_info>
  <brief_title>Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease</brief_title>
  <official_title>Assessment of Adrenal Functions in Patients With Autosomal Dominant Polycystic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to evaluate the hypothalamus-pituitary-adrenal axis in autosomal dominant polycystic
      kidney disease (ADPKD) patients. Twenty two ADPKD patients and 27 healthy subjects were
      enrolled.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CONTEXT: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
      kidney disease and extrarenal manifestations may be observed in many organ systems.
      Hypothalamus-pituitary-adrenal axis in patients with ADPKD was not evaluated extensively.

      OBJECTIVE: We aimed to evaluate the hypothalamus-pituitary-adrenal axis in ADPKD patients.

      METHODS: Twenty two ADPKD patients and 27 healthy subjects were enrolled. Basal
      dehydroepiandrosterone-sulfate (DHEAS) levels and cortisol and dehydroepiandrosterone
      responses to low dose short adrenocorticotropin stimulation test were assessed. Correlation
      analyses of these parameters with glomerular filtration rates, renal volumes and pain
      characteristics in patients with ADPKD were done.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inadequate response to tetracosactin infusion</measure>
    <time_frame>30 and 60 minutes after the drug is administered</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Autosomal Dominant Polycystic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with autosomal dominant polycystic kidney disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tetracosactin</intervention_name>
    <description>1 microgram tetracosactin, intravenous injection, once for the test</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Synacthen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  Diagnosis of autosomal dominant polycystic kidney disease

        Exclusion Criteria:

          -  A glomerular filtration rate below 60 ml/min

          -  History of recent major surgery

          -  Systemic infections with fever

          -  Significant hirsutism (Ferriman Gallwey score≥8)

          -  Congenital adrenal hyperplasia

          -  Late onset congenital adrenal hyperplasia

          -  Systemic corticosteroid use (including previous use)

          -  Topical corticosteroid use

          -  Menstrual irregularity

          -  History of thromboembolism

          -  Uncontrolled diabetes or hypertension

          -  History of psychosis

          -  Pregnancy

          -  Lactation

          -  History of hypersensitivity to tetracosactin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>56 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tevfik Ecder, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatih Tufan, Fellow</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neşe Çolak, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine Division of Endocrinology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bora Uslu, Fellow</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kültigin Türkmen, Fellow</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mükremin Uysal, Fellow</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nilüfer Alpay, Fellow</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rian Dişçi, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bledi Çerkezi, Fellow</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Istanbul Medical Faculty Department of Radiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul Univetsity, Istanbul Medical Faculty, Department of Internal Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34390</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2007</study_first_submitted>
  <study_first_submitted_qc>January 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2008</study_first_posted>
  <last_update_submitted>February 17, 2009</last_update_submitted>
  <last_update_submitted_qc>February 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2009</last_update_posted>
  <responsible_party>
    <name_title>Tevfik Ecder</name_title>
    <organization>Istanbul University, Istanbul Medical Faculty, Division of Nephrology</organization>
  </responsible_party>
  <keyword>Autosomal dominant polycystic kidney disease</keyword>
  <keyword>Adrenal functions</keyword>
  <keyword>Renal volume</keyword>
  <keyword>Glomerular filtration rate</keyword>
  <keyword>Adrenal Cortex Function Tests</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney, Autosomal Dominant</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Cosyntropin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>August 29, 2016</submitted>
    <returned>October 20, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

